According to Vision Research Reports, the global rapid medical diagnostic kits market size is projected to reach over USD 23.4 billion by 2027.
The global rapid medical diagnostic kits market size was valued at USD 16.5 billion in 2019 and expanding at a CAGR of 4.2% from forecast period 2020 to 2027.
The growing prevalence of infections caused by multidrug-resistant bacteria has led to high demand for rapid diagnosis. Moreover, the outbreak of COVID-19, caused by a newly discovered coronavirus, has created a significant need for rapid diagnostic tests to manage and control the pandemic.
Some of the factors that have played a vital role in the rising prevalence of emerging diseases are genetic variation in hosts and pathogens, population pressure, and environmental change. Rapid detection of chronic diseases, especially infectious diseases, is necessary and should be accurate and affordable too. It helps minimize the need for multiple patient visits and facilitates timely treatment and control of infectious disease outbreaks such as COVID-19. In response to the pandemic, many manufacturers of diagnostic tests are focusing on the development of rapid and easy-to-use point of care COVID-19 diagnostic tests to facilitate testing outside of lab settings. For instance, on March 21, 2020, Cepheid, a subsidiary of Danaher Corporation, launched a novel COVID-19 diagnostic test namely Cepheid Xpert Xpress SARS-CoV-2 post Emergency Use Authorization (EUA) approval from the FDA.
Regulatory bodies such as WHO, CDC, and European Centre for Disease Prevention and Control, are engaged in active recording of data on incidence and prevalence of infectious diseases to control the disease systematically. These agencies work together with local governments to achieve overall control of the treatment and management of infectious diseases. For example, the Global Influenza Programme (GIP), by WHO, provides technical support, strategic guidance, and coordination activities concerning a zoonotic, pandemic, and seasonal influenzas.
Growing prevalence of infectious diseases including tuberculosis, malaria, HIV/AIDS, pneumonia, hepatitis, and influenza is one of the major factors propelling the market growth. According to WHO, around 58.0 million people were diagnosed and treated for tuberculosis between 2000 and 2018 across the globe. The WHO also stated that in 2018, over 228.0 million malaria cases occurred around the world, with over 93.0% cases being reported from Africa, 3.4% from Southeast Asia, and 2.1% from the Eastern Mediterranean region.
Report Highlights
Some of the prominent players in the rapid medical diagnostic kits market include:
ACON Laboratories, Inc.
Abbott Laboratories
Artron Laboratories Inc.
Alfa Scientific Designs, Inc.
Becton, Dickinson and Company
BTNX, Inc.
bioMérieux SA
Cardinal Health
Bio-Rad Laboratories, Inc.
Danaher Corporation
Creative Diagnostics
Meridian Bioscience, Inc.
F. Hoffmann-La Roche AG
McKesson Medical-Surgical, Inc
Sight Diagnostics Ltd
Trinity Biotech
Zoetis
Market Segmentation
Product Outlook
Over-The-Counter (OTC) Kits
Professional Kits
Technology Outlook
Lateral Flow
Agglutination
Solid Phase
Other Technologies
Application Outlook
Blood Glucose Testing
Infectious Disease Testing
Cardiometabolic Testing
Pregnancy and Fertility Testing
Fecal Occult Blood Testing
Coagulation Testing
Toxicology Testing
Lipid Profile Testing
Other Applications
End-use Outlook
Hospitals & Clinics
Home Care
Diagnostic Laboratories
Regional Outlook
North America
The U.S.
Canada
Europe
Germany
The U.K.
France
Italy
Spain
Russia
Asia Pacific
Japan
China
India
South Korea
Australia
Singapore
Latin America
Brazil
Mexico
Argentina
Middle East Africa (MEA)
South Africa
Saudi Arabia
UAE
Market Overview
The Rapid medical diagnostic kits market research report covers definition, classification, product classification, product application, development trend, product technology, competitive landscape, industrial chain structure, industry overview, national policy and planning analysis of the industry, the latest dynamic analysis, etc., and also includes major. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level.
The report provides size (in terms of volume and value) of Rapid medical diagnostic kits market for the base year 2019 and the forecast between 2020 and 2027. Market numbers have been estimated based on form and application. Market size and forecast for each application segment have been provided for the global and regional market.
This report focuses on the global Rapid medical diagnostic kits market status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Rapid medical diagnostic kits market development in United States, Europe and China.
It is pertinent to consider that in a volatile global economy, we haven’t just conducted Rapid medical diagnostic kits market forecasts in terms of CAGR, but also studied the market based on key parameters, including Year-on-Year (Y-o-Y) growth, to comprehend the certainty of the market and to find and present the lucrative opportunities in market.
In terms of production side, this report researches the Rapid medical diagnostic kits capacity, production, value, ex-factory price, growth rate, market share for major manufacturers, regions (or countries) and type.
In terms of consumption side, this report focuses on the consumption of Rapid medical diagnostic kits by regions (countries) and application.
Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of production analysis, the authors of the report have provided reliable estimations and calculations for global revenue and volume by Type segment of the global Rapid medical diagnostic kits market. These figures have been provided in terms of both revenue and volume for the period 2016 to 2027. Additionally, the report provides accurate figures for production by region in terms of revenue as well as volume for the same period. The report also includes production capacity statistics for the same period.
With regard to production bases and technologies, the research in this report covers the production time, base distribution, technical parameters, research and development trends, technology sources, and sources of raw materials of major Rapid medical diagnostic kits market companies.
Regarding the analysis of the industry chain, the research of this report covers the raw materials and equipment of Rapid medical diagnostic kits market upstream, downstream customers, marketing channels, industry development trends and investment strategy recommendations. The more specific analysis also includes the main application areas of market and consumption, major regions and Consumption, major Chinese producers, distributors, raw material suppliers, equipment providers and their contact information, industry chain relationship analysis.
The research in this report also includes product parameters, production process, cost structure, and data information classified by region, technology and application. Finally, the paper model new project SWOT analysis and investment feasibility study of the case model.
Overall, this is an in-depth research report specifically for the Rapid medical diagnostic kits industry. The research center uses an objective and fair way to conduct an in-depth analysis of the development trend of the industry, providing support and evidence for customer competition analysis, development planning, and investment decision-making. In the course of operation, the project has received support and assistance from technicians and marketing personnel in various links of the industry chain.
Rapid medical diagnostic kits market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to Rapid medical diagnostic kits market.
Prominent players in the market are predicted to face tough competition from the new entrants. However, some of the key players are targeting to acquire the startup companies in order to maintain their dominance in the global market. For a detailed analysis of key companies, their strengths, weaknesses, threats, and opportunities are measured in the report by using industry-standard tools such as the SWOT analysis. Regional coverage of key companies is covered in the report to measure their dominance. Key manufacturers of Rapid medical diagnostic kits market are focusing on introducing new products to meet the needs of the patrons. The feasibility of new products is also measured by using industry-standard tools.
Key companies are increasing their investments in research and development activities for the discovery of new products. There has also been a rise in the government funding for the introduction of new Rapid medical diagnostic kits market. These factors have benefited the growth of the global market for Rapid medical diagnostic kits. Going forward, key companies are predicted to benefit from the new product launches and the adoption of technological advancements. Technical advancements have benefited many industries and the global industry is not an exception.
New product launches and the expansion of already existing business are predicted to benefit the key players in maintaining their dominance in the global market for Rapid medical diagnostic kits. The global market is segmented on the basis of region, application, en-users and product type. Based on region, the market is divided into North America, Europe, Asia-Pacific, Latin America and Middle East and Africa (MEA).
In this study, the years considered to estimate the market size of Rapid medical diagnostic kits are as follows:
Reasons to Purchase this Report:
- Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
- Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
- Market value USD Million and volume Units Million data for each segment and sub-segment
- Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
Research Methodology:
In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report.
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.
Market Size Estimation
Top-down and bottom-up approaches are used to estimate and validate the global market size for company, regional division, product type and application (end users).
The market estimations in this report are based on the selling price (excluding any discounts provided by the manufacturer, distributor, wholesaler or traders). Market share analysis, assigned to each of the segments and regions are achieved through product utilization rate and average selling price.
Major manufacturers & their revenues, percentage splits, market shares, growth rates and breakdowns of the product markets are determined through secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or others factors are accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Vision Research Reports and presented in this report.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation. Extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report.
Secondary Sources
Secondary Sources occupies approximately 25% of data sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on. This research study includes secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; investor presentations; and SEC filings of companies.
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
The study objectives of this report are:
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Rapid Medical Diagnostic Kits Market, By Product
7.1. Rapid Medical Diagnostic Kits Market, by Product Type, 2020-2030
7.1.1. Over the Counter (OTC) Kits
7.1.1.1. Market Revenue and Forecast (2016-2030)
7.1.2. Professional Kits
7.1.2.1. Market Revenue and Forecast (2016-2030)
Chapter 8. Global Rapid Medical Diagnostic Kits Market, By Autonomy
8.1. Rapid Medical Diagnostic Kits Market, by Autonomy, 2020-2030
8.1.1. Lateral Flow
8.1.1.1. Market Revenue and Forecast (2016-2030)
8.1.2. Agglutination
8.1.2.1. Market Revenue and Forecast (2016-2030)
8.1.3. Solid Phase
8.1.3.1. Market Revenue and Forecast (2016-2030)
8.1.4. Other Technologies
8.1.4.1. Market Revenue and Forecast (2016-2030)
Chapter 9. Global Rapid Medical Diagnostic Kits Market, By Propulsion Type
9.1. Rapid Medical Diagnostic Kits Market, by Propulsion Type, 2020-2030
9.1.1. Blood Glucose Testing
9.1.1.1. Market Revenue and Forecast (2016-2030)
9.1.2. Infectious Disease Testing
9.1.2.1. Market Revenue and Forecast (2016-2030)
9.1.3. Cardiometabolic Testing
9.1.3.1. Market Revenue and Forecast (2016-2030)
9.1.4. Pregnancy and Fertility Testing
9.1.4.1. Market Revenue and Forecast (2016-2030)
9.1.5. Fecal Occult Blood Testing
9.1.5.1. Market Revenue and Forecast (2016-2030)
9.1.6. Coagulation Testing
9.1.6.1. Market Revenue and Forecast (2016-2030)
9.1.7. Toxicology Testing
9.1.7.1. Market Revenue and Forecast (2016-2030)
9.1.8. Lipid Profile Testing
9.1.8.1. Market Revenue and Forecast (2016-2030)
9.1.9. Other Applications
9.1.9.1. Market Revenue and Forecast (2016-2030)
Chapter 10. Global Rapid Medical Diagnostic Kits Market, By End-use Type
10.1. Rapid Medical Diagnostic Kits Market, By End-use Type, 2020-2030
10.1.1. Hospitals & Clinics
10.1.1.1. Market Revenue and Forecast (2016-2030)
10.1.2. Home Care
10.1.2.1. Market Revenue and Forecast (2016-2030)
10.1.3. Diagnostic Laboratories
10.1.3.1. Market Revenue and Forecast (2016-2030)
Chapter 11. Global Rapid Medical Diagnostic Kits Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Product (2016-2030)
11.1.2. Market Revenue and Forecast, by Autonomy (2016-2030)
11.1.3. Market Revenue and Forecast, by Propulsion Type (2016-2030)
11.1.4. Market Revenue and Forecast, By End-use Type (2016-2030)
11.1.5. U.S.
11.1.5.1. Market Revenue and Forecast, by Product (2016-2030)
11.1.5.2. Market Revenue and Forecast, by Autonomy (2016-2030)
11.1.5.3. Market Revenue and Forecast, by Propulsion Type (2016-2030)
11.1.5.4. Market Revenue and Forecast, By End-use Type (2016-2030)
11.1.6. Rest of North America
11.1.6.1. Market Revenue and Forecast, by Product (2016-2030)
11.1.6.2. Market Revenue and Forecast, by Autonomy (2016-2030)
11.1.6.3. Market Revenue and Forecast, by Propulsion Type (2016-2030)
11.1.6.4. Market Revenue and Forecast, By End-use Type (2016-2030)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Product (2016-2030)
11.2.2. Market Revenue and Forecast, by Autonomy (2016-2030)
11.2.3. Market Revenue and Forecast, by Propulsion Type (2016-2030)
11.2.4. Market Revenue and Forecast, By End-use Type (2016-2030)
11.2.5. UK
11.2.5.1. Market Revenue and Forecast, by Product (2016-2030)
11.2.5.2. Market Revenue and Forecast, by Autonomy (2016-2030)
11.2.5.3. Market Revenue and Forecast, by Propulsion Type (2016-2030)
11.2.5.4. Market Revenue and Forecast, By End-use Type (2016-2030)
11.2.6. Germany
11.2.6.1. Market Revenue and Forecast, by Product (2016-2030)
11.2.6.2. Market Revenue and Forecast, by Autonomy (2016-2030)
11.2.6.3. Market Revenue and Forecast, by Propulsion Type (2016-2030)
11.2.6.4. Market Revenue and Forecast, By End-use Type (2016-2030)
11.2.7. France
11.2.7.1. Market Revenue and Forecast, by Product (2016-2030)
11.2.7.2. Market Revenue and Forecast, by Autonomy (2016-2030)
11.2.7.3. Market Revenue and Forecast, by Propulsion Type (2016-2030)
11.2.7.4. Market Revenue and Forecast, By End-use Type (2016-2030)
11.2.8. Rest of Europe
11.2.8.1. Market Revenue and Forecast, by Product (2016-2030)
11.2.8.2. Market Revenue and Forecast, by Autonomy (2016-2030)
11.2.8.3. Market Revenue and Forecast, by Propulsion Type (2016-2030)
11.2.8.4. Market Revenue and Forecast, By End-use Type (2016-2030)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Product (2016-2030)
11.3.2. Market Revenue and Forecast, by Autonomy (2016-2030)
11.3.3. Market Revenue and Forecast, by Propulsion Type (2016-2030)
11.3.4. Market Revenue and Forecast, By End-use Type (2016-2030)
11.3.5. India
11.3.5.1. Market Revenue and Forecast, by Product (2016-2030)
11.3.5.2. Market Revenue and Forecast, by Autonomy (2016-2030)
11.3.5.3. Market Revenue and Forecast, by Propulsion Type (2016-2030)
11.3.5.4. Market Revenue and Forecast, By End-use Type (2016-2030)
11.3.6. China
11.3.6.1. Market Revenue and Forecast, by Product (2016-2030)
11.3.6.2. Market Revenue and Forecast, by Autonomy (2016-2030)
11.3.6.3. Market Revenue and Forecast, by Propulsion Type (2016-2030)
11.3.6.4. Market Revenue and Forecast, By End-use Type (2016-2030)
11.3.7. Japan
11.3.7.1. Market Revenue and Forecast, by Product (2016-2030)
11.3.7.2. Market Revenue and Forecast, by Autonomy (2016-2030)
11.3.7.3. Market Revenue and Forecast, by Propulsion Type (2016-2030)
11.3.7.4. Market Revenue and Forecast, By End-use Type (2016-2030)
11.3.8. Rest of APAC
11.3.8.1. Market Revenue and Forecast, by Product (2016-2030)
11.3.8.2. Market Revenue and Forecast, by Autonomy (2016-2030)
11.3.8.3. Market Revenue and Forecast, by Propulsion Type (2016-2030)
11.3.8.4. Market Revenue and Forecast, By End-use Type (2016-2030)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Product (2016-2030)
11.4.2. Market Revenue and Forecast, by Autonomy (2016-2030)
11.4.3. Market Revenue and Forecast, by Propulsion Type (2016-2030)
11.4.4. Market Revenue and Forecast, By End-use Type (2016-2030)
11.4.5. GCC
11.4.5.1. Market Revenue and Forecast, by Product (2016-2030)
11.4.5.2. Market Revenue and Forecast, by Autonomy (2016-2030)
11.4.5.3. Market Revenue and Forecast, by Propulsion Type (2016-2030)
11.4.5.4. Market Revenue and Forecast, By End-use Type (2016-2030)
11.4.6. North Africa
11.4.6.1. Market Revenue and Forecast, by Product (2016-2030)
11.4.6.2. Market Revenue and Forecast, by Autonomy (2016-2030)
11.4.6.3. Market Revenue and Forecast, by Propulsion Type (2016-2030)
11.4.6.4. Market Revenue and Forecast, By End-use Type (2016-2030)
11.4.7. South Africa
11.4.7.1. Market Revenue and Forecast, by Product (2016-2030)
11.4.7.2. Market Revenue and Forecast, by Autonomy (2016-2030)
11.4.7.3. Market Revenue and Forecast, by Propulsion Type (2016-2030)
11.4.7.4. Market Revenue and Forecast, By End-use Type (2016-2030)
11.4.8. Rest of MEA
11.4.8.1. Market Revenue and Forecast, by Product (2016-2030)
11.4.8.2. Market Revenue and Forecast, by Autonomy (2016-2030)
11.4.8.3. Market Revenue and Forecast, by Propulsion Type (2016-2030)
11.4.8.4. Market Revenue and Forecast, By End-use Type (2016-2030)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Product (2016-2030)
11.5.2. Market Revenue and Forecast, by Autonomy (2016-2030)
11.5.3. Market Revenue and Forecast, by Propulsion Type (2016-2030)
11.5.4. Market Revenue and Forecast, By End-use Type (2016-2030)
11.5.5. Brazil
11.5.5.1. Market Revenue and Forecast, by Product (2016-2030)
11.5.5.2. Market Revenue and Forecast, by Autonomy (2016-2030)
11.5.5.3. Market Revenue and Forecast, by Propulsion Type (2016-2030)
11.5.5.4. Market Revenue and Forecast, By End-use Type (2016-2030)
11.5.6. Rest of LATAM
11.5.6.1. Market Revenue and Forecast, by Product (2016-2030)
11.5.6.2. Market Revenue and Forecast, by Autonomy (2016-2030)
11.5.6.3. Market Revenue and Forecast, by Propulsion Type (2016-2030)
11.5.6.4. Market Revenue and Forecast, By End-use Type (2016-2030)
Chapter 12. Company Profiles
12.1. ACON Laboratories, Inc.
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Abbott Laboratories
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Artron Laboratories Inc.
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Alfa Scientific Designs, Inc.
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Becton, Dickinson and Company
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. BTNX, Inc.
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. bioMérieux SA
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Cardinal Health
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Bio-Rad Laboratories, Inc.
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Danaher Corporation
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
12.11. Creative Diagnostics
12.11.1. Company Overview
12.11.2. Product Offerings
12.11.3. Financial Performance
12.11.4. Recent Initiatives
12.12. Meridian Bioscience, Inc.
12.12.1. Company Overview
12.12.2. Product Offerings
12.12.3. Financial Performance
12.12.4. Recent Initiatives
12.13. F. Hoffmann-La Roche AG
12.13.1. Company Overview
12.13.2. Product Offerings
12.13.3. Financial Performance
12.13.4. Recent Initiatives
12.14. McKesson Medical-Surgical, Inc.
12.14.1. Company Overview
12.14.2. Product Offerings
12.14.3. Financial Performance
12.14.4. Recent Initiatives
12.15. Sight Diagnostics Ltd.
12.15.1. Company Overview
12.15.2. Product Offerings
12.15.3. Financial Performance
12.15.4. Recent Initiatives
12.16. Trinity Biotech
12.16.1. Company Overview
12.16.2. Product Offerings
12.16.3. Financial Performance
12.16.4. Recent Initiatives
12.17. Zoetis
12.17.1. Company Overview
12.17.2. Product Offerings
12.17.3. Financial Performance
12.17.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
Glossary of Terms